Latest News

Go Back

Newsletter: Q1 2017

January 1, 2017 admin

« Celerion Announces Celexus as a Premier Safety Reporting Tool for Phase I Clinical Trials

Celerion Appoints Dr. Marc Hoffman as Chief Medical Officer »

Celerion 2026. All Rights Reserved. Privacy & Legal